Subscribe to Updates

What the COVID-19 Vaccine Means for Your Return to Work Strategy

Written by Jennifer Koenig

The long-awaited COVID-19 vaccine has brought a lot of questions from employers about the safety, efficacy, distribution, timeline, and even if they can require their employees to get vaccinated. Below is a breakdown of what the vaccine could mean for your population, availability, and policies you need to know if mandating the vaccine.

The Vaccine Is Just One Tool In Our Toolkit

The vaccine is not the end all be all to controlling the pandemic. While it will help expedite herd immunity and reduce the severity of COVID-19, it is just one additional tool in our toolkit. To date, there is no data showing that the vaccine reduces transmission, making masks, social distancing, good hand washing, and symptom tracking all still necessary, regardless of your organization’s vaccination rate.

The Vaccine 101

As of this writing, there are three vaccines being distributed in the US. Two are mRNA based and one is viral vector, all with FDA Emergency Use Authorization. They are all considered effective and safe:

  • The Pfizer vaccine is an mRNA vaccine 
  • The Moderna vaccine is an mRNA vaccine. 
  • The Johnson & Johnson vaccine is a viral vector vaccine 

It’s important to note that the vaccine should be administered in a medical facility, at least for right now for a few key reasons: logistical hurdles and safety. The Pfizer vaccine has to be stored at -94° F and Moderna at -4° F meaning special refrigeration equipment is needed to keep the vaccines effective. Although rare, there is potential for significant adverse side effects of the vaccine. Controlling the risks and ensuring the safety of people receiving it is a wise step at this phase of the rollout.

Further complicating things, just as the vaccine rollout was getting underway, a new variant was recently identified in several countries. It has the potential to impact the effectiveness of the vaccines currently being administered. The manufacturers think there are still protections, but it is too early to tell.

One final note; there are over 50 other vaccines currently in development. The AstraZeneca vaccine was recently approved for use in the UK and is about 90% effective. Studies are ongoing and we anticipate more progress being made in the number and types of vaccines available. We expect to see much progress on this front in the coming months. 

Rollout & Distribution

The Advisory Committee on Immunization Strategies (ACIP) run by the CDC has launched a tiered rollout driven at the state and local levels. They have provided guidance and recommendations, but local governments are managing the logistics and prioritization of the rollout. While we don’t anticipate it always being this way, especially as the Biden administration takes control in the coming week, it’s an area HealthCheck360 continues to watch.

You can access your state’s policy, in the “State & Territory COVID-19 Vaccine Information” section here.


Currently, the vaccine is in phase 1A of rollout and available to health care employees and long-term care facility residents in many places, while others have progressed to phase 1B and 1C. 

After phase 1A, frontline essential employees in tier 1B will be up next. In many cases, this includes:

  • Emergency personnel like firefighters, police officers, corrections officers
  • Food and agricultural workers like meatpacking and processing facilities, food manufacturers, and grocery store workers
  • Public service workers like postal service employees and public transit
  • Education staff like teachers, daycare workers, and support staff
  • Manufacturing workers making essential products and services

Below is a summary of the recommended populations for each tier.

Phase 1A Phase 1B Phase 1C Phase 2
  • Health care Workers
  • Long-term Care Residents
  • People 75+
  • Frontline essential employees (non-healthcare)
  • People aged 65 - 74 years old
  • People with high-risk medical conditions aged 16-64
  • General Population


Currently, the vaccine is not available for purchase through private channels. As of the writing of this article, HealthCheck360 is not aware of any availability outside of the governmental distribution and administration. We do expect this to change as the knowledge around the risks and side effects increases and new vaccines with fewer logistical hurdles are available.

Requiring the Vaccine

While requiring vaccines in certain workplaces is not new (think the flu shot for health care workers), there is a lot of controversy around the COVID-19 vaccine given the rate at which it was developed, and many unknown questions surrounding the risks and long-term effects.

The EEOC has stated that employers can require the COVID-19 vaccine. If you’re planning on requiring your employees to get the vaccine once it’s available to the general public, keep in mind that you need to offer a reasonable accommodation for employees with disabilities and religious objections. This could mean, getting a different vaccine that doesn’t affect their medical condition, teleworking, or even reassigning the employee to another role. When communicating the vaccine requirement, the process for requesting accommodations should also be documented and clearly visible.

Employers can also ask employees for proof that they’ve received the COVID-19 vaccine as it will not be considered a “medical examination” under the ADA. Keep in mind that questions you ask around the vaccine could get a little too close to disability-related questions which does violate the ADA, so use caution with any pre-screening or vaccine-related questions.

Perhaps a better approach that many employers are exploring is encouraging vaccination among employees through education, promoting community and personal well-being, and as part of the company’s well-being program and strategy. In some environments, the need to require the vaccine may not be an issue because there is enough employee interest on their own without needing a mandate from the employer.

Recommendations for Employers

Given all of the unknowns around the vaccine availability for the general public at this stage, what should employers be focusing on right now? Here are a few ideas:

  • Look at the risk and role profile of your company. Are you able to work from home? Are some segments of your business able to work from home? Distancing measures are still some of the best ways to limit the spread, especially with the new variant and increasing cases. If you are a non-healthcare essential workplace, especially where people are in close contact with each other, stay up-to-date on your local and state guidance about availability for phase 1B in your area so you can begin offering vaccines as soon as reasonably possible.
  • Gauge employee interest in the vaccine. Gathering some insights now into how many employees are interested in getting the vaccine, even at these early stages, will arm you with valuable information around the likelihood that you would need to require the vaccine. Polls and surveys are fast ways to get a pulse on the feelings of your employees.
  • Have a multifaceted plan. Keep in mind, what you do today does not have to be what you do tomorrow. You can recommend and encourage employees get the vaccine and then require it for any of the holdouts. In addition, the pandemic and vaccine landscaping is changing by the day. Staying flexible will be required of us all as navigate the ever-changing environment.
  • Keep your mitigation practices in place. Even after employees are receiving the vaccine, plan to keep your symptom tracking, cleaning schedules, mask requirements, and social distancing policies in place. The vaccine is shown to reduce the severity of the disease, but it’s not yet known if it reduces transmission.

We are hopeful for the future as more COVID-19 vaccines and research are released. As regulations change and availability of the vaccine progresses, HealthCheck360 will continue to keep you informed.

Check out our COVID-19 Resource Center for free tools available to employers and employees. If you’re not doing any kind of symptom tracking today, we encourage you to explore this option as it’s another measure in your COVID-19 mitigation toolkit.


Topics: Wellness Regulation, Corporate Well-being, COVID-19



Learn More


Learn More